Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice-Reference-Cited by-同舟云学术

Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice

Published:2017-08-07 Issue:1 Volume:243 Page:89-99
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol

Author:

Gao Yang¹,Lin Pengfei¹²,Lydon John P³,Li Qinglei¹^ORCID

Affiliation:

1. Department of Veterinary Integrative Biosciences, College of Veterinary Medicine; Texas A&M University; College Station TX USA

2. Key Laboratory of Animal Biotechnology of the Ministry of Agriculture, College of Veterinary Medicine; Northwest A&F University; Yangling Shaanxi PR China

3. Department of Molecular and Cellular Biology; Baylor College of Medicine; Houston TX USA

Funder

New Faculty Start-up Funds

Texas A and M University

National Institutes of Health

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference61 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Type I and II endometrial cancers: have they different risk factors?;Setiawan;J Clin Oncol,2013

3. Targeting PI3K signalling in cancer: opportunities, challenges and limitations;Engelman;Nat Rev Cancer,2009

4. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems;Podsypanina;Proc Natl Acad Sci U S A,1999

5. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice;Daikoku;Cancer Res,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling;Biomedicine & Pharmacotherapy;2023-12

2. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis;Modern Pathology;2023-02

3. Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma;Oncology Research;2023

4. Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition;Scientific Reports;2022-09-01

5. EZH2 and Endometrial Cancer Development: Insights from a Mouse Model;Cells;2022-03-07